According to Cooper Companies's latest financial reports the company has a price-to-book ratio of 2.34.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | N/A | -100% |
2023-12-31 | 2.48 | 9.12% |
2022-12-31 | 2.27 | -23.71% |
2021-12-31 | 2.98 | -36.1% |
2020-12-31 | 4.67 | 7.42% |
2019-12-31 | 4.34 | 14.69% |
2018-12-31 | 3.79 | 13% |
2017-12-31 | 3.35 | 5.89% |
2016-12-31 | 3.17 | 30.66% |
2015-12-31 | 2.42 | -19.66% |
2014-12-31 | 3.02 | 22.95% |
2013-12-31 | 2.45 | 21.06% |
2012-12-31 | 2.03 | 16.34% |
2011-12-31 | 1.74 | 12.4% |
2010-12-31 | 1.55 | 38.37% |
2009-12-31 | 1.12 | 114.4% |
2008-12-31 | 0.5223 | -55.36% |
2007-12-31 | 1.17 | -19.42% |
2006-12-31 | 1.45 | -19.02% |
2005-12-31 | 1.79 | -57.81% |
2004-12-31 | 4.25 | 19.26% |
2003-12-31 | 3.56 | 43.54% |
2002-12-31 | 2.48 |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 5.11 | 118.69% | ๐บ๐ธ USA |
Novartis NVS | 4.05 | 73.33% | ๐จ๐ญ Switzerland |
Boston Scientific BSX | 5.07 | 117.30% | ๐บ๐ธ USA |
Teleflex TFX | 2.20 | -5.81% | ๐บ๐ธ USA |
Utah Medical Products UTMD | 1.95 | -16.47% | ๐บ๐ธ USA |
Atrion ATRI | 2.79 | 19.68% | ๐บ๐ธ USA |